NICHOLS et al. V. TABAKOFF et al. - Page 30




             Interference No. 104,522 Paper 108                                                                              
             Nichols v. Tabakoff Page 30                                                                                     
                     "The issue of derivation is one of fact and the party asserting derivation has the                      
             burden of proof... . Derivation is shown by a prior, complete conception of the claimed                         
             subject matter and communication of the complete conception to the party charged with                           
             the derivation." Hedgewick v. Akers, 497 F.2d 905, 908, 182 USPQ 167, 169 (CCPA                                 
             1974). In Gambro Lundia AB v. Baxter Healthcare Corp., 110 F.3d 1573, 1578, 42                                  
             USPQ2d 1378, 1383 (Fed. Cir. 1997), the court held that the "correct standard" for                              
             derivation is 'Whether the communication enabled one of ordinary skill in the art to                            
             make the patented invention."                                                                                   
                     Nichols contends that Tabakofrs request to Dr. Nichols to synthesize a 4-urea                           
             kynurenic acid derivative was simply a research plan because Tabakoff did not suggest                           
             a specific chemical structure for the derivative or a synthesis method therefor. Nichols                        
             alleges that "extensive" research was required to obtain an operable synthesis method.                          
             [NB, pp. 28-30.) Nichols relies on a March 23, 1994 experiment recorded in Dr. Nichols'                         
             lab notebook (Ex 2020) to show complete conception, i.e., "knowledge of both the                                
             specific chemical structure of the compound and an operative method of making it" (id.,                         
             p. 32). Nichols further contends that it communicated that information to Tabakoff as                           
             shown in letters and e-mails from Tabakoff acknowledging Nichols as "the entity                                 
             responsible for the synthesis of these compounds" (id., p. 25).                                                 
                     Tabakoff argues that none of the evidence shows that Nichols knew of or had                             
             made any 4-urea kynurenic acid derivatives before Dr. Snell requested Dr. Nichols to                            
             make such compounds. Tabakoff further argues that Dr. Snell sent scientific                                     
             publications to Dr. Nichols on the synthesis of similar types of prior art compounds.                           








Page:  Previous  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  Next 

Last modified: November 3, 2007